Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Soleno Therapeutics Inc (SLNO)

Soleno Therapeutics Inc (SLNO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 86,102
  • Shares Outstanding, K 79,724
  • Annual Sales, $ 0 K
  • Annual Income, $ -24,640 K
  • 60-Month Beta 0.43
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.27
Trade SLNO with:

Options Overview

Details
  • Implied Volatility 165.21%
  • Historical Volatility 104.44%
  • IV Percentile 56%
  • IV Rank 14.04%
  • IV High 594.65% on 05/12/21
  • IV Low 95.05% on 01/20/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 433
  • Volume Avg (30-Day) 1,038
  • Put/Call OI Ratio 0.35
  • Today's Open Interest 20,618
  • Open Int (30-Day) 17,224

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.08
  • Number of Estimates 1
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year -0.16
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9655 +11.86%
on 05/19/21
1.6700 -35.33%
on 06/02/21
+0.0700 (+6.93%)
since 05/18/21
3-Month
0.9305 +16.07%
on 05/14/21
1.6700 -35.33%
on 06/02/21
-0.5300 (-32.92%)
since 03/18/21
52-Week
0.9305 +16.07%
on 05/14/21
3.3599 -67.86%
on 02/09/21
-0.8200 (-43.16%)
since 06/18/20

Most Recent Stories

More News
Thinking about buying stock in Irving Resources, Soligenix, Exela Technologies, Soleno Therapeutics, or Onconova Therapeutics?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for IRV, SNGX, XELA, SLNO, and ONTX.

IRVRF : 1.4000 (+1.45%)
IRV.CN : 1.710 (unch)
ONTX : 7.00 (-3.71%)
SLNO : 1.0800 (+0.93%)
SNGX : 1.1200 (-6.67%)
XELA : 1.2800 (-6.57%)
Soleno Therapeutics Receives Orphan Drug Designation from FDA for Diazoxide Choline for the Treatment of Glycogen Storage Disease Type 1a

Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that the U.S. Food and...

SLNO : 1.0800 (+0.93%)
Soleno Therapeutics to Host Webinar Highlighting DCCR for Treatment of Prader-Willi Syndrome at European Congress on Endocrinology 2021

Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that the Company will host...

SLNO : 1.0800 (+0.93%)
Soleno Therapeutics to Participate in the Oppenheimer Rare & Orphan Disease Summit

Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Anish Bhatnagar, M.D.,...

SLNO : 1.0800 (+0.93%)
Thinking about buying stock in LightPath Technologies, Minerva Neurosciences, Cerecor, Eloxx Pharmaceuticals, or Soleno Therapeutics?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LPTH, NERV, CERC, ELOX, and SLNO.

ELOX : 2.08 (unch)
NERV : 2.63 (-1.87%)
CERC : 3.67 (+4.26%)
LPTH : 2.48 (+2.06%)
SLNO : 1.0800 (+0.93%)
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results

Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today provided a corporate update, and...

SLNO : 1.0800 (+0.93%)
Soleno Therapeutics Announces Presentation of Positive Behavioral Data from Ongoing Extension Study of DCCR for Treatment of Prader-Willi Syndrome

Results Show Improvement in Multiple Behavioral Domains Following Treatment with DCCR

SLNO : 1.0800 (+0.93%)
Soleno Therapeutics Participates in Prader-Willi Syndrome (PWS) DCCR Town Hall

Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that Anish Bhatnagar, M.D.,...

SLNO : 1.0800 (+0.93%)
Soleno Therapeutics (SLNO) Enters Oversold Territory

Soleno Therapeutics (SLNO) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

SLNO : 1.0800 (+0.93%)
Pacira (PCRX) Gets FDA Nod for Exparel in Pediatric Patients

The FDA approves Pacira's (PCRX) Exparel for use in patients aged six years and older for single-dose infiltration to produce postsurgical local analgesia.

PCRX : 59.64 (-1.34%)
CANF : 2.28 (-2.15%)
OPHLF : 21.5000 (-5.29%)
SLNO : 1.0800 (+0.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Soleno Therapeutics Inc. is a healthcare company. It develops and commercializes diagnostics, devices and therapeutics addressing unmet medical needs. The Company offers products consists of CoSense end-tidal carbon monoxide Monitor, NeoPIP Infant Resuscitator and Accessories and Serenz Nasal Relief....

See More

Key Turning Points

3rd Resistance Point 1.1233
2nd Resistance Point 1.1067
1st Resistance Point 1.0933
Last Price 1.0800
1st Support Level 1.0633
2nd Support Level 1.0467
3rd Support Level 1.0333

See More

52-Week High 3.3599
Fibonacci 61.8% 2.4319
Fibonacci 50% 2.1452
Fibonacci 38.2% 1.8585
Last Price 1.0800
52-Week Low 0.9305

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar